KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Net Margin: 2010-2025

Historic Net Margin for Nektar Therapeutics (NKTR) over the last 16 years, with Sep 2025 value amounting to -296.76%.

  • Nektar Therapeutics' Net Margin fell 14315.00% to -296.76% in Q3 2025 from the same period last year, while for Sep 2025 it was -181.12%, marking a year-over-year decrease of 42.00%. This contributed to the annual value of -120.89% for FY2024, which is 18542.00% up from last year.
  • According to the latest figures from Q3 2025, Nektar Therapeutics' Net Margin is -296.76%, which was up 15.42% from -350.85% recorded in Q2 2025.
  • Nektar Therapeutics' Net Margin's 5-year high stood at 24.80% during Q4 2024, with a 5-year trough of -736.94% in Q2 2022.
  • Over the past 3 years, Nektar Therapeutics' median Net Margin value was -222.93% (recorded in 2024), while the average stood at -260.29%.
  • Per our database at Business Quant, Nektar Therapeutics' Net Margin slumped by 29,388bps in 2022 and then soared by 48,755bps in 2023.
  • Over the past 5 years, Nektar Therapeutics' Net Margin (Quarterly) stood at -587.42% in 2021, then skyrocketed by 28,498bps to -302.43% in 2022, then skyrocketed by 12,626bps to -176.17% in 2023, then surged by 20,097bps to 24.80% in 2024, then plummeted by 14,315bps to -296.76% in 2025.
  • Its last three reported values are -296.76% in Q3 2025, -350.85% for Q2 2025, and -443.80% during Q1 2025.